| Endo International is a specialty pharmaceutical company focused on generic and branded pharmaceuticals. Co. operates four business segments: U.S. Branded - Specialty and Established Pharmaceuticals, which includes branded prescription products in urology, urologic oncology, endocrinology, pain and orthopedics; U.S. Branded - Sterile Injectables, which consists of branded sterile injectable products; U.S. Generic Pharmaceuticals, which includes products in the pain management, urology, central nervous system disorders and women's health; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder and pain. We show 42 historical shares outstanding datapoints in our ENDP shares outstanding history coverage, used to compute ENDP market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ENDP market cap history over the course of time is important for investors
interested in comparing ENDP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ENDP versus a peer is one thing; comparing
ENDP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ENDP can fluctuate over the course of history.
With this page we aim to empower investors researching ENDP by allowing them to research the ENDP market cap history.